EP2540261A1 — Intraocular medicament delivery device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-01-02 · 13y expired
What this patent protects
Described is a medicament delivery device (1) comprising a body (2) adapted to be placed on the eye (3) and a reservoir (7) formed in the body (2) containing a medicament. The body (2) has a first surface (4) adapted to contact at least a portion of the eye (3) and be centered ar…
USPTO Abstract
Described is a medicament delivery device (1) comprising a body (2) adapted to be placed on the eye (3) and a reservoir (7) formed in the body (2) containing a medicament. The body (2) has a first surface (4) adapted to contact at least a portion of the eye (3) and be centered around a cornea. At least one projection (5) is formed on the first surface (4). The projection (5) includes a channel (6) adapted to create a fluid flow path for the medicament from the reservoir (7) to a terminal end of the projection (5).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.